1.1 Research Objective

1.2 Product Overview

1.3 Market Segmentation

2.1 Qualitative Research
2.1.1 Primary & Secondary Sources

2.2 Quantitative Research
2.2.1 Primary & Secondary Sources

2.3 Breakdown of Primary Research Respondents, By Region

2.4 Assumption for the Study

2.5. Data Triangulation

Executive Summary: Global Spatial OMICS Market

4.1. Drivers
4.1.1. Growing potential of spatial OMICS as a cancer diagnostic tool
4.1.2. Increasing adoption of spatial OMICS in drug discovery and development

4.2. Restraints
4.2.1. Lack of skilled professionals

4.3. Opportunities
4.3.1. Growing usage of spatial OMICS for biomarker identification

4.4. Impact of COVID-19 on Spatial OMICS Market

4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition

5.1. Key Insights

5.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
5.2.1. FFPE
5.2.2. Fresh Frozen

6.1. Key Insights

6.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
6.2.1. Academic & Translational Research Institutes
6.2.2. Pharmaceutical and Biotechnology Companies

7.1. Key Insights

7.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
7.2.1. Spatial Proteomics
7.2.2. Spatial Transcriptomics
7.2.3. Spatial Genomics

8.1. Key Insights

8.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
8.2.1. Instruments
8.2.2. Consumables
8.2.3. Software

9.1. Key Insights

9.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
9.2.1. Sample Preparation
9.2.2. Instrumental Analysis
9.2.3. Data Analysis

10.1. Key Insights

10.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
10.2.1. North America 
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Germany
10.2.2.2. France
10.2.2.3. U.K.
10.2.2.4. Rest of Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. Rest of Asia Pacific
10.2.4. ROW
10.2.4.1. Latin America
10.2.4.2. Middle East and Africa

11.1. Key Insights

11.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
11.2.1. By Sample Type
11.2.2. By End-Use
11.2.3. By Technology
11.2.4. By Product
11.2.5. By Workflow
11.2.6. By Country

12.1. Key Insights

12.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
12.2.1. By Sample Type
12.2.2. By End-Use
12.2.3. By Technology
12.2.4. By Product
12.2.5. By Workflow
12.2.6. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
13.2.1. By Sample Type
13.2.2. By End-Use
13.2.3. By Technology
13.2.4. By Product
13.2.5. By Workflow
13.2.6. By Country

14.1. Key Insights

14.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
14.2.1. By Sample Type
14.2.2. By End-Use
14.2.3. By Technology
14.2.4. By Product
14.2.5. By Workflow
14.2.6. By Country

15.1. 10x Genomics
15.2. S2 Genomics, Inc.
15.3. NanoString Technologies
15.4. Seven Bridges Genomics
15.5. PerkinElmer, Inc.
15.6. Bio-Techne
15.7. Danaher Corporation
15.8. IonPath, Inc.
15.9. Millennium Science Pty Ltd
15.10. Akoya Biosciences, Inc.
15.11. Fluidigm Corporation
15.12. Diagenode Diagnostics
15.13. Biognosys AG
15.14. Rebus Biosystems
15.15. Ultivue, Inc.
15.16. BioSpyder Technologies
15.17. Bruker